Consumer Warning: Bureau Of Prescription Health Charging For Free Assistance

If you’ve been doing business or contemplating doing business with the Missouri-based Bureau of Prescription Health the Better Business Bureau (BBB) is advising consumers to avoid this company. The Bureau of Prescription Health sounds like a trustworthy and reputable company (mainly because of the use of the word “Bureau”) but are in fact charging consumers … Read more

The Misbranding of Vioxx Results In A Nearly $1 Billion Resolution

Last week the Justice Department announced that Merck, Sharp, & Dohme, an American pharmaceutical company, has agreed to resolve criminal charges and civil claims in relation to their promotion and marketing of the painkiller, Vioxx (rofecoxib) by paying $950 million. Yes, you read that right; just shy of $1 billion. Under the resolution terms, Mereck … Read more

FTC Asks To Restrict Pay-For-Delay Deals To Lower Consumers’ Health Care Costs

The Federal Trade Commission (FTC) has released a report of data pertaining to the 2011 fiscal year which showed that pharmaceutical companies continued an anticompetitive trend of paying potential generic rivals to delay the introduction of low-cost prescription drug alternatives for American consumers. If you’re like me, generic pharmaceutical drugs save my life, not only … Read more